Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Nov 15 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC. SECURES ADDITIONAL FINANCING WITH STRATEGIC
INVESTMENT FROM INVESTORS LED BY PHARMACYTE BIOTECH
* FEMASYS INC - $6.85 MILLION UPFRONT INVESTMENT PROVIDES
$23
MILLION TOTAL CASH RUNWAY INTO SECOND HALF 2025
* FEMASYS- STRATEGIC INVESTMENT IN CO IS IN FORM OF $6.85
MILLION
AMOUNT OF A SENIOR UNSECURED CONVERTIBLE NOTE WHICH MATURES
NOVEMBER 2025
Source text for Eikon: ID:nGNX8Nczq3
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview